FirstCarolinaCare Insurance Company Step Therapy Requirements

Similar documents
Step Therapy Requirements. Effective: 03/01/2015

Step Therapy Requirements. Effective: 12/01/2016

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 05/01/2018

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

ANTICONVULSANTS. Details

Step Therapy Requirements

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ADHD STIMULANTS-S(SHC)

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALPHA GLUCOSIDASE INHIBITOR THERAPY

STEP THERAPY ALGORITHMS PUP Select Formulary

SmithRx Standard Formulary Step Therapy List

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

2018 Step Therapy Criteria

Step Therapy Medications

Step Therapy Criteria 2019

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

ATYPICAL ANTIPSYCHOTICS

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

2017 Step Therapy Criteria

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ALLERGIC CONJUNCTIVITIS AGENTS

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Commissioner for the Department for Medicaid Services Selections for Preferred Products

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

ADHD STIMULANTS - SCORE

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

ADHD STIMULANTS - SCORE

These medications will require preauthorization (PA) for HMSA Medicare Part D members.

2019 PDP Basic Step Therapy Document

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

Step Therapy Group. Atypical Antipsychotic Agents

Step Therapy Requirements

Step Therapy Program Precision Formulary

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Before a Step 2 medication is covered You get a prescription

Cigna Drug and Biologic Coverage Policy

Blue Medicare HMO Essential 2015 Quantity Limit List Blue Medicare Rx Standard 2015 Quantity Limit List

CONTRAINDICATIONS TABLE

Step Therapy Criteria

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

2019 Simply Step Therapy Document

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

ANTICONVULSANT THERAPY

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

2013 Step Therapy (ST) Criteria

How do I request an exception to the Liberty Health Advantage s Formulary?

ANGIOTENSIN RECEPTOR BLOCKERS

Avoid paying too much for your prescriptions

ANTICONVULSANT STEP THERAPY

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Generics. Lead with. Prescription Step Therapy Program

Transcription:

ANALGESICS, NARCOTICS KADIAN MORPHINE SULFATE ER PRIOR CLAIM FOR MORPHINE SULFATE SUSTAINED ACTION TABLET (MS CONTIN) WITHIN THE PAST 120 DAYS.

ANTIBACTERIALS (EENT) BESIVANCE PRIOR CLAIM FOR CIPROFLOXACIN OPHTHALMIC DROPS, CIPROFLOXACIN OPHTHALMIC OINTMENT, OR OFLOXACIN OPHTHALMIC DROPS WITHIN THE LAST 120 DAYS.

ANTIDIABETIC AGENTS - INSULINS LEVEMIR LEVEMIR FLEXPEN PRIOR CLAIM FOR INSULIN GLARGINE (LANTUS OR LANTUS SOLOSTAR) WITHIN THE PAST 120 DAYS.

ANTIDIABETIC AGENTS - MISCELLANEOUS INVOKANA PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA, A COMBINATION OF SULFONYLUREA AND METFORMIN, PIOGLITAZONE, OR COMBINATION PIOGLITAZONE AND METFORMIN WITHIN THE PAST 120 DAYS.

ANTIPSYCHOTIC AGENTS FANAPT FAZACLO INVEGA LATUDA SAPHRIS PRIOR CLAIM FOR A GENERIC ANTIPSYCHOITIC SUCH AS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, CLOZAPINE ORAL DISINTEGRATING TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE, AND ABILIFY WITHIN THE PAST 365 DAYS.

ANTIULCER AGENTS LANSOPRAZOLE PRIOR CLAIM FOR GENERIC FEDERAL LEGEND OMEPRAZOLE OR PANTOPRAZOLE WITHIN THE PAST 120 DAYS.

ARIPIPRAZOLE ABILIFY ABILIFY DISCMELT PRIOR CLAIM FOR A GENERIC ATYPICAL ANTIPSYCHOTIC SUCH AS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, CLOZAPINE ORAL DISINTEGRATING TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE OR AN SSRI OR SNRI SUCH AS CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, OR VENLAFAXINE WITHIN THE PAST 120 DAYS.

B VERSUS D ADMINISTRATIVE STEP CYCLOPHOSPHAMIDE METHOTREXATE TREXALL PRIOR CLAIM FOR A RHEUMATOID ARTHRITIS DRUG WITHIN THE PAST 120 DAYS.

BUDESONIDE-FORMOTEROL FUMERATE SYMBICORT PRIOR CLAIM FOR ADVAIR OR DULERA WITHIN THE PAST 120 DAYS.

COPD DALIRESP PRIOR CLAIM FOR ONE COPD AGENT (LAMA, LABA, SAMA, SAMA/SABA) SUCH AS ATROVENT, COMBIVENT, SPIRIVA, ARCAPTA, SEREVENT, OR FORADIL WITHIN THE LAST 120 DAYS.

GLP-1 ANALOGS BYDUREON BYETTA PRIOR CLAIM FOR EITHER METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (E.G. GLYBURIDE, GLIPIZIDE), COMBINATION OF A SULFONYLUREA AND METFORMIN, A THIAZOLIDINEDIONE (E.G. PIOGLITAZONE, ROSIGLITAZONE), OR A COMBINATION THIAZOLIDINEDIONE AND METFORMIN WITHIN THE PAST 120 DAYS.

HYPERURICEMIC AGENTS ULORIC PRIOR CLAIM FOR ALLOPURINOL OR COLCHICINE WITHIN THE PAST 120 DAYS

KETOLIDES KETEK PRIOR CLAIM FOR A MACROLIDE WITHIN THE PAST 120 DAYS.

MULTIPLE SCLEROSIS AGENTS AVONEX AVONEX ADMINISTRATION PACK BETASERON EXTAVIA PRIOR CLAIM FOR REBIF (INTERFERON BETA-1A) OR COPAXONE (GLATIRAMIR ACETATE) WITHIN THE PAST 120 DAYS.

NSAIDS, CYCLOOXYGENASE INHIBITOR-TYPE CELEBREX PRIOR CLAIM FOR ONE (1) NON-STEROIDAL ANTI-INFLAMMATORY AGENTS WITHIN THE PAST 120 DAYS.

OPHTHALMIC ANTIHISTAMINES BEPREVE PATADAY PATANOL PRIOR CLAIM FOR LEVOCETIRIZINE OR CROMOLYN SODIUM EYE DROPS WITHIN THE PAST 120 DAYS.

QUETIAPINE FUMARATE EXTENDED RELEASE SEROQUEL XR PRIOR CLAIM FOR A GENERIC ATYPICAL ANTIPSYCHOTIC SUCH AS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, CLOZAPINE ORAL DISINTEGRATING TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE OR AN SSRI OR SNRI SUCH AS CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, OR VENLAFAXINE AND ABILIFY WITHIN THE PAST 365 DAYS.

RENIN ANGIOTENSION SYSTEM INHIBITORS AMTURNIDE AZOR BENICAR BENICAR HCT DIOVAN EXFORGE EXFORGE HCT MICARDIS MICARDIS HCT TEKAMLO TEKTURNA TEKTURNA HCT TEVETEN TEVETEN HCT TRIBENZOR PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS.

ROTIGOTINE NEUPRO PRIOR CLAIM FOR IMMEDIATE RELEASE PRAMIPEXOLE OR IMMEDIATE RELEASE ROPINIROLE WITHIN THE PAST 120 DAYS.